This research-on-research study describes efforts to develop non-Cochrane systematic reviews (SRs) by analysing demographical and time-course collaborations between international institutions using protocols registered in the International Prospective Register of Systematic Reviews (PROSPERO) or published in scientific journals. We have published an a priori protocol to develop this study. Protocols published in scientific journals were searched in MEDLINE/PubMed and Embase databases using the query terms 'Systematic review'[Title] AND 'protocol' [Title] from February 2011 to December 2017. Protocols registered at PROSPERO during the same period were obtained by web scraping all non-Cochrane records with a Python script. After excluding protocols with less than 90% fulfilled or duplicated, they were classified as published 'only in PROSPERO', 'only in journals', or in both 'journals and PROSPERO'. Results of data and metadata extraction using text-mining processes were curated by two reviewers. Datasets and R scripts are freely available to facilitate reproducibility. We obtained 20,814 protocols of non-Cochrane SRs. While 'unique protocols' by re-viewers' institutions from 60 countries were the most frequent, to prepare 'collaborative protocols' a median of 6 (2-150) institutions were involved from 130 different countries. Ranked list of countries involved in overall protocol production were the UK, the U.S.. Most protocols were registered only in PROSPERO. However, the number of protocols published in scientific journals (924) or in both PROSPERO and journals (807) has progressively increased over the last three years. Syst Rev and BMJ Open published more than half of the total protocols. While most productive countries were PLOS 1/11 involved in 'unique' and 'collaborative' protocols, less productive countries only participated in 'collaborative' protocols that were mainly published only in PROSPERO. Our results suggest that although most countries were involved in producing in solitary protocols of non-Cochrane SRs during the study period, it would be desirable to develop new strategies to promote international collaborations, especially with less productive countries.
Systematic reviews (SRs) and meta-analyses (MAs), the standards for evidence 2 synthesis of primary studies, are extremely useful to support decision making processes 3 in the context of Health Systems [1] . However it is desirable that these decisions being 4 supported by reviews of highest methodological quality and have the lowest risk of 5 bias [2] . The Cochrane Handbook for Systematic Reviews of Interventions states that a 6 protocol should be prepared before publishing an SR [3] . In 2010, PRISMA statement 7 advocated registration of SR protocols [1, 2] . Preparing an a priori protocol will reduce 8 the potential for bias in the review process and increase transparency of analysis and 9 results [4] . Furthemore, if the content of a protocol is available for public access it could 10 also also reduce duplication [5, 6] , peer review before starting the review process, and 11 audit discrepancies between protocol and the finally produced SR [7] [8] [9] . 12 Bias moves away from the possibilities of finding the truth we seek. Rigorously 13 following the methodological agreements established by the scientific community 14 minimizes bias and reduces uncertainty about the estimates we make. One of the 15 proposals to reduce bias in SRs is to develop a comprehensive protocol containing the 16 sources of primary data, procedures for searching, extracting, filtering, selection and 17 analysis of data, as well as the analytical and methodological tools that will be used to 18 conduct the research. For now, it is only essential that such protocols are prepared 19 before making the first analysis and they can be consulted at any time, leaving the trace 20 that were elaborated much before the final results were published [10] . 21 Therefore, there are two main features of a protocol: fist, it should contain all 22 necessary instructions to reproduce the same results from the respective SR; second, it 23 should be prepared before the SR is conducted. Currently, a protocol can be freely 24 viewable to the scientific community with the possibility of tracking dates to make 25 ensure that the protocol is created prior to the review: public repositories and scientific 26 journals. PROSPERO (International prospective register of systematic reviews) is an 27 international database of prospectively registered systematic reviews funded by the 28 National Institute for Health Research (NIHR). Scientists worldwide use the database 29 and less than a decade has reached the landmark achievement of 30,000 registrations.
30
The database is free and open to all researchers planning to conduct an SR and for those 31 searching for registered, ongoing, or completed reviews to develop meta-epidemiology 32 studies. The PROSPERO Advisory Group Statement of Founding Principles centres on 33 free access to both registering and searching the database and is as inclusive as possible, 34 while achieving the key aims of avoiding duplication and minimising bias in SRs.
35
The second option is to publish the protocol in a scientific journal. This option 36 allows peer reviewers and editors to assess scientifically the quality of the protocol.
37
Through their comments and suggestions, reviewers may suggest changes to improve 38 methodological quality. However, there is still no empirical evidence from 39 meta-epidemiological studies that these changes in protocol will be crucial for improving 40 the quality of the SR. There are many journals that accept protocols of SR for 41 publication. Some of them are 'BMJ Open' (https://bmjopen.bmj.com/) and 42 'Systematic Reviews' (https://goo.gl/mFShxv).
43
No matter where protocols are published, a descriptive analysis of these documents 44
PLOS
2/11 can give us a glimpse of the efforts made by researchers to carry out SRs. We recently 45 found (data not published) that only a small percentage of these protocols ends up 46 being published their results, and this could be an unknown source of bias not studied 47 so far, similar to those meant for many randomized clinical trials (RCTs) that were 48 registered in public repositories such as ClinicalTrials.gov but never been published. In 49 a first approximation to this problem, we aimed to describe comprehensively how 50 different reviewers represented by the institutions and countries to which they belong, 51 make efforts to design these protocols and their strategies to conduct reviews.
52
To date, no study has formally assessed the relationships between reviewers,
53
represented by their respective institution or country, when elaborating an a priori 54 protocol to develop a non-Cochrane systematic review, analysing co-working patterns, 55 and evolution of strategies to make these protocols publicly accessible.
56
Materials and methods
57
A priori published protocol 58 We published an a priori protocol in Systematic Reviews [11] . This protocol describe Registers or protocols with less than 90% of sections fulfilled or those that were 73 duplicated (i.e., those sharing titles and reviewers) were dropped from the dataset. An 74 R script automatically performed the screening process. Subsequently, the results were 75 subjected to human verification by two reviewers (JG-M and MA-L).
76
Dataset and variables 77 A working .csv file, which included only those variables we were interested in for further 78 analysis, was obtained (Supplementary methods). Protocols with different reviewer's 79 affiliation countries were considered to be the result of international collaboration and 80 their respective countries were analysed as they co-appeared in the protocol as unlisted 81 and tagged as contributing to 'Collaborative protocols'. Protocols with unique 82 reviewers' affiliation country were considered to be produced by a unique country and 83 were tagged as 'Unique protocols'. country. Considering the entire list of affiliation-associated countries for all co-reviewers 89 per protocol, we displayed a world map that represents in different colours the number 90 of times any country has been involved in any protocol.
91
Data visualization, and statistical analysis 92 Graphs were produced and statistics were analysed using several packages of R Our planned search strategy was published in Systematic Reviews and compared with 105 the final reported review methods. The methods of web scraping, filtering and selection 106 did not changed. However, as this is the first article, the project constitutes only a 107 partial descriptive analysis as compared with the main goals described in the above 108 mentioned protocol.
109
Ethical considerations
110
Since our study did not collect primary data, no formal ethical assessment and informed 111 consent are not required.
112

Results
113
Search results
114
After scraping 30,000 PROSPERO records, 5,362 documents were excluded as they were 115 not fulfilled and 903 were duplicated versions of other protocols ( Fig. 1 ). After text 116 mining and manually supervising the obtained dataset, 4,364 protocols were not 117 considered because they were lacking in crucial information required for the analyses.
118
By searching bibliographic databases, we obtained 1,732 protocols of SRs published in 119 scientific journals. Only 807 protocols were shared by both PROSPERO and journal 120 datasets ( Fig. 2b) . 'only in PROSPERO' (Fig. 2a ), and followed far behind by protocols published 'only in 128 journals' or published in both 'journal and PROSPERO' (Fig. 2b) . worldwide. However, we show that African countries in comparison with other countries, 156 produce lower number of protocols and the lowest number of protocols are produced by 157 most of these countries. Most protocols (17, 431 ; 90%) were authored by reviewers from 158 institutions of a single country from a total of 90 countries (31.5% countries worldwide). 159 In contrast, a few protocols (1, 938) were elaborated by collaboration with institutions 160 from two or more countries from a list of 130 (45.62% of 285 countries worldwide) ( Fig. 161  5) . The wordclouds ( Fig. 1 d-f ) and bar diagrams ( Fig. 1g-i) show a predominance 162 participation by institutions from countries such as the UK, the U.S., Australia, Brazil, 163 Canada, China, and the Netherlands in producing protocols either in isolation or in 164 collaboration with others countries (Fig. 1e, 1h , and 4b). the Netherlands and France in the collaborative list; c) almost all the countries involved 174 in producing 'unique protocols' participated in the creation of 'collaborative protocols' 175 as this is more productive than working in isolation; d) countries that only participated 176 in collaborative protocols were the least productive ( Fig. 5 ).
177
Analysis of time-course patterns 178 Fig. 6 displays 'the year of the first protocol published' by 'source of publication ('only 179 PROSPERO', 'PROSPERO journal', 'only journal')' and by 'country'. To simplify the 180 analysis, only protocols without collaborations between countries are considered in this 181 plot. There seem to be four different patterns. In the first pattern, the most productive 182 and collaborative countries (the UK, Canada, Australia, China, Germany, Italy, the 183 U.S., and the Netherlands) started producing protocols very early and submitted them 184 to PROSPERO or published in journals; however, it was only after 1-3 years that they 185 started publishing protocols in both PROSPERO and journals. In the second pattern, 186 audience, and focusing on relevant issues through appropriate methodologies [12] . This 217 will be possible with the growing innovation in tools and platforms that would enable 218 more efficient SR production in collaboration.
219
Registration forms of protocols submitted to PROSPERO are only checked against 220 the scope for inclusion in the repository and for clarity of content. Once accepted an 221 audit trail of major changes to planned methods may be checked at any time, even after 222 the SR published. Ideally, registration should take place before the researchers started 223 formal screening against inclusion criteria, but reviews are eligible as long as they have 224 not progressed beyond the point of completing data extraction. However, accomplishing 225 these goals is still conditioned by the reviewers integrity. Dawid Pieper and Katharina 226 Allers recently suggested than a priori design of an SR may not have the same 227 advantages and potential to reduce the risk of bias in SRs compared to those of RCTs. 228 They argue that future 'living SRs', involving new workflow and collaboration tools, 229 text mining and machine learning technologies, emerging reusable data depositories, and 230 shared ontologies and harmonized data transfer protocols can be expected to decrease 231 any potential manipulations in future.
232
Since 2011, there have been few meta-epidemiological studies about the content and 233 use of PROSPERO. A descriptive analysis of the number of PROSPERO registrations 234 and website usage from 2011 to 2017 have recently published, exploring the 235 epidemiological characteristics and completeness of primary outcome pre-specification in 236 a small sample of PROSPERO records [13] . They highlight the exponential increase in 237 registered protocols at PROSPERO between 2011 and 2017. However, these authors 238 recognize that there are still many caveats regarding the real utility of making a 239 document, which is not methodologically reviewed, available of public access. These 240 authors, one of them a member of the PROSPERO's international advisory group, raise 241 three issues that will certainly generate future debate about new strategies for future 242 improvement in PROSPERO: how closely published SRs adhere to the planned methods 243 -PROSPERO registrations?; can specification of greater outcomes in PROSPERO 244 registrations prevent inclusion and reporting biases?; and do registered SRs address the 245 necessary questions?.
246
Limitations and strengths 247 Our study includes analyzing the largest sample of SR protocols produced during the 248 last seven years. We did not perform PROSPERO registration record sampling [13] . 249 Rather, our objective was to get the entire universe of registers, from the first document 250 to the last one registered just before the date of web scraping, and not a representative 251 sample of them. The search specificity for non-Cochrane PROSPERO registration 252 records was based on Python script that was designed to recognize only the format of 253 these records, which differs from registration records for Cochrane and non-human 254 studies. These cannot be scraped using our script due to the structural differences in 255 PROSPERO forms. Thus, the sensitivity and specificity for the web scraping is 100%. 256 The present study, however, also had several limitations. First, we used countries as 257 a proxy for reviewers or reviewers' institutions. Better size of information granularity limitation to afford the project to use countries as the unit of analysis. We have used 262 this approach previously to analyse how the author-paper affiliation network 263 architecture influences the methodological quality of SRs and MAs of psoriasis [14] .
264
Second, our study is limited to protocols in non-Cochrane SRs. Cochrane Reviews are 265 demonstrated to have better methodological quality and lower bias risk than 266 non-Cochrane SRs [15, 16] . The Cochrane Database of Systematic Reviews (CDSR) is 267 the leading resource for Cochrane SRs and protocols. Protocols for Cochrane Reviews 268 have also been published at PROSPERO from 1 October 2013. This fact introduces a 269 gap at PROSPERO from 2011 to 2013 with only non-Cochrane SRs. Another area of 270 particular concern in relation to non-Cochrane reviews is the failure to register reviews 271 at the outset. Registration of Cochrane reviews is mandatory with publication of a 272 protocol a priori. Future studies comparing methodological quality of protocols registered 'only in 294 PROSPERO, 'only in journals', and in 'both PROSPERO and journals' should provide 295 empirical evidence for an a priori peer-reviewing process of protocols before authors 296 start SR development. Furthermore, by exploring if modifications suggested by 297 peer-reviewers after submitting an SR protocol to a journal significantly improves the 298 quality of protocols (i.e. assessed using PRISMA for Protocols extension), and even to 299 increase the methodological quality and to reduce the risk of bias in the final SR would 300 be of great interest. collaborative relationship between countries during the analysis phase of our study. We 314 are grateful to all the contributors and to the advisory group of the PROSPERO registry. 315 We are also grateful to the reviewers for their helpful comments and suggestions. We 
